Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Syndax Pharmaceuticals (NASDAQ:SNDX) reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Syndax Pharmaceuticals missed estimated earnings by -1.0%, reporting an EPS of $-1.0 versus an estimate of $-0.99.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $0.05 which was followed by a 0.0% increase in the share price the next day.
To track all earnings releases for Syndax Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: SNDX